GSK3β activation is a key driver of resistance to Raf inhibition in BRAF mutant melanoma cells.

{"title":"GSK3β activation is a key driver of resistance to Raf inhibition in BRAF mutant melanoma cells.","authors":"Diana Crisan, Susanne Schatz, Heidi Hainzl, Fang Zhao, Annette Paschen, Maria Crisan, Adrian Baican, Karin Scharffetter-Kochanek, Abhijit Basu","doi":"10.18632/oncotarget.28711","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":19499,"journal":{"name":"Oncotarget","volume":"16 ","pages":"257-259"},"PeriodicalIF":0.0000,"publicationDate":"2025-04-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11970936/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Oncotarget","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.18632/oncotarget.28711","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}